Mixed traditional Chinese medicine for treating chronic pulmonary heart disease

Abstract

The invention discloses a mixed traditional Chinese medicine for treating a chronic pulmonary heart disease. The mixed traditional Chinese medicine is prepared from the following traditional Chinese medicinal materials in parts by weight: 15 parts of purple quartz, 15 parts of magnetite, 2 parts of agilawood, 9 parts of codonopsis pilosula, 5 parts of cordyceps militaris, 6 parts of radix aconiti carmichaeli, 15 parts of prepared rhizome of rehmannia, 10 parts of the bark of white mulberry, 5 parts of ephedra, 8 parts of honeysuckle, 10 parts of dried tangerine or orange peel, and 5 parts of cinnamon. As the pathogenesis of the chronic pulmonary heart disease comprises: 1. qi deficiency of lung and kidney; 2. phlegm heat accumulated in the lung; 3. exogenous evil in the body, the mixed traditional Chinese medicine for treating the chronic pulmonary heart disease is prepared from the traditional Chinese medicinal materials capable of warming the kidney to culture vitality, collecting qi, relieving asthma, eliminating phlegm by cooling, and dispelling the wind and the toxic materials to achieve an obvious treatment effect.

Description

technical field [0001] The invention relates to a multi-traditional Chinese medicine combination medicine capable of treating chronic cor pulmonale and belongs to the technical field of traditional Chinese medicine. Background technique [0002] Chronic cor pulmonale, also known as chronic pulmonary heart disease, is a heart disease caused by chronic lesions of the chest wall, lungs, and pulmonary arteries, resulting in increased pulmonary circulatory resistance and pulmonary arterial hypertension, resulting in right ventricular hypertrophy, dilation, and even right-sided heart failure. . The incidence of chronic pulmonary heart disease is high in our country, especially in cold, humid areas and mountainous areas. The incidence of miners and regular smokers is higher. According to the statistics of our country in recent years, the average annual prevalence of pulmonary heart disease is 0.4~0.5%. . The age of onset is mostly over 40 years old, and the older the age, the hig...

AI Technical Summary

Problems solved by technology

Antibiotics or surgery can temporarily control the condition and alleviate the temporary threat of serious illness, but cannot fundamentally treat the root cause of the disease